Complete Wegovy vs Mounjaro Dosing & Switch Guide
Why Patients Switch: Wegovy vs Mounjaro Dosing Considerations
When evaluating Wegovy vs Mounjaro dosing for a potential switch, patients often cite different tolerability profiles, cost considerations, or availability concerns. Wegovy follows a structured 16-week escalation from 0.25mg to 2.4mg maintenance, whilst Mounjaro escalates from 2.5mg to 15mg maximum over 12 weeks. The dosing frequencies differ significantly—both are weekly injections, but the escalation timeline and final maintenance doses vary considerably.
Your prescriber will assess your current Mounjaro dose and treatment response to determine an appropriate Wegovy starting point. Most patients switching from established Mounjaro therapy may start Wegovy at 0.5mg or 1mg rather than the standard 0.25mg initiation dose. This personalised approach minimises treatment interruption whilst ensuring optimal tolerability during the transition period.
Wegovy vs Mounjaro Dosing: Complete Price Comparison
Cost analysis reveals potential savings when switching from Mounjaro to Wegovy through EverydayMeds. Our Wegovy pricing starts at £79.99 for 0.25mg starter pens, £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for 2.4mg maintenance doses. New customers can apply discount code FIRST40 at checkout, whilst returning customers use code DOSE25 for additional savings.
Our Getting Started bundles provide convenient dose progression options—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99 for patients switching from lower Mounjaro doses. The Elevate Trio bundle (1mg, 1.7mg & 2.4mg) at £499.99 suits patients transitioning from higher Mounjaro doses, providing three months of step-up therapy in one order.
Clinical Evidence: Wegovy vs Mounjaro Dosing Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes across the STEP trial programme. The STEP 1 trial demonstrated approximately 15% average weight loss at 68 weeks with the 2.4mg maintenance dose, as reported by Wilding et al., NEJM, 2021. STEP 5 showed sustained weight loss of approximately 15.2% maintained over two years of treatment.
Both medications work through different mechanisms despite similar outcomes. Direct comparison of trial results isn't appropriate due to different study designs and patient populations. Your prescriber can evaluate your individual response to current treatment and expected outcomes when considering Wegovy vs Mounjaro dosing options for your specific circumstances.
How Wegovy Works: Mechanism for Dosing Decisions
Understanding Wegovy's mechanism helps inform dosing decisions when switching treatments. As a GLP-1 receptor agonist, semaglutide mimics the natural incretin hormone that regulates blood sugar and appetite after meals. It works primarily on brain appetite centres to reduce hunger signals and promote satiety with smaller portions. The medication also slows gastric emptying, extending the feeling of fullness between meals. This mechanism requires gradual dose escalation to allow physiological adaptation and minimise gastrointestinal side effects. The 16-week escalation schedule from 0.25mg to 2.4mg ensures optimal tolerability whilst building therapeutic effectiveness over time.
Ordering Process: Seamless Wegovy vs Mounjaro Switching
Switching between treatments through EverydayMeds involves a streamlined 3-minute online clinical assessment covering your current treatment, dose, duration, and switching rationale. Our prescribers review switching requests within 3 working days (or 24 hours with express service) to ensure clinical appropriateness and determine optimal starting doses. Once approved, your Wegovy prescription is dispatched via next-day cold-chain delivery to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the switching process. Clinical support remains available for dose adjustments, side effect management, or treatment optimisation during your transition period.
Storage Advantages: Wegovy vs Mounjaro Dosing Practicalities
Storage considerations favour Wegovy for patients with active lifestyles or frequent travel commitments. Whilst both medications require refrigeration at 2-8°C before first use, Wegovy maintains stability for 6 weeks at room temperature (below 30°C) once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, providing greater flexibility for extended trips or temporary storage situations. The FlexTouch pen design offers precise dose delivery with clear dose escalation markings, and the weekly injection schedule aligns with structured lifestyle routines. Proper storage maintains medication effectiveness throughout the 16-week dose escalation period and ongoing maintenance therapy.
Dose Conversion Guidance: Mounjaro to Wegovy Transitions
Prescribers use clinical judgement rather than direct dose conversion when switching from Mounjaro to Wegovy, as the medications work through different mechanisms with varying potency profiles. Patients established on Mounjaro 2.5mg-5mg may start Wegovy at 0.5mg, whilst those on Mounjaro 7.5mg-10mg might begin with Wegovy 1mg to minimise treatment gap effects. Higher Mounjaro doses (12.5mg-15mg) may warrant Wegovy initiation at 1mg or 1.7mg, depending on individual tolerance and treatment response history.
The switching timeline typically involves completing your current Mounjaro pen, then beginning Wegovy within 7 days to maintain therapeutic continuity. Some patients may require modified escalation schedules—spending additional weeks at lower doses or accelerating through well-tolerated doses based on previous treatment experience. Your prescriber will provide specific switching instructions tailored to your current therapy and individual circumstances.
Complete Switch & Save: EverydayMeds Advantage
EverydayMeds offers unique advantages for patients considering Wegovy vs Mounjaro dosing switches through our comprehensive service model. Our clinical team understands both medications intimately, ensuring smooth transitions with appropriate dose selection and timing guidance. Express prescriber review options minimise treatment interruptions, whilst our cold-chain delivery commitment medication integrity from our GPhC-registered premises (#9012878) directly to your door.
Both Wegovy and Mounjaro remain available through our service, allowing flexible switching in either direction based on clinical response and prescriber recommendations. Our transparent pricing structure, combined with new customer (FIRST40) and returning customer (DOSE25) discount codes, makes switching both clinically appropriate and financially sensible. Visit our weight loss collection to begin your clinical assessment and explore switching options with full prescriber support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
